The Europe In Vitro Toxicity Testing Market would witness market growth of 10.4% CAGR during the forecast period (2022-2028).
In vitro methods are now widely employed in safety evaluation, risk appraisal, and toxicity testing by all regulatory authorities and sectors. The advantages of in vitro procedures over testing on animals are the primary factor behind their usage. The in vitro approach is mostly utilized to find out how a drug's toxicity works and how it affects a cell or tissue. The introduction of the Ames Mutagenic Assay increased the popularity of non-animal testing over animal testing.
Regulatory hurdles and political obstacles are also anticipated to enhance the sector. Many countries are more likely to push this industry because of ethical concerns about animals. Animal testing restrictions are severe in countries like Europe, thus enterprises operating in this area are likely to flout them and opt for in vitro toxicology testing instead for a variety of product development and research purposes. Other growing Asian nations are expected to follow suit, resulting in improved and faster development of in vitro testing methods. Enhanced economic circumstances will also aid in the acceptance of new technology, resulting in immediate potential enhancements in the cosmetics, chemical, food industries, and pharmaceutical.
The processes and laws for the marketing authorization of pharmaceutical products for human use in the European Union are principally outlined in Regulation 2001/83/EC of the European Parliament and Council. The European Medicines Agency's Protocol on Non-Clinical Local Tolerance Assessing of Medicinal Products should be followed while testing skin sensitization.
Due to increased healthcare awareness connected to blood reaction and donating, greater per-capita income and expenditure, and enhanced patient infrastructure, Europe is a significantly large in vitro toxicity testing market.
The sensitizing potential of drug products applied to the skin or plan to participate should be assessed in risk assessments before being administered to people, according to this recommendation (EMA, 2015). This encourages the use of in vitro toxicity testing.
The Germany market dominated the Europe In Vitro Toxicity Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2.4 billion by 2028. The UK market is estimated to grow at a CAGR of 9.5% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 11.2% during (2022 - 2028).
Based on Type, the market is segmented into Absorption, Toxic Substances, and Dose. Based on Technology, the market is segmented into Cell Culture Technologies, High Throughput Technologies, and Toxicogenomics. Based on End User, the market is segmented into Cosmetics & Households Products, Pharmaceuticals Industry, Food Industry, Chemicals, and Industry. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global In Vitro Toxicity Testing Market Size will Hit $37.5 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., General Electric (GE) Co., AstraZeneca PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Acacia Pharma Group Plc, GlaxoSmithKline PLC, Helsinn Healthcare SA., and Heron Therapeutics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Absorption
- Toxic Substances
- Dose
By Technology
- Cell Culture Technologies
- High Throughput Technologies
- Toxicogenomics
By End User
- Cosmetics & Households Products
- Pharmaceuticals Industry
- Food Industry
- Chemicals Industry
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- General Electric (GE) Co.
- AstraZeneca PLC
- Catalent, Inc.
- Laboratory Corporation of America Holdings
- Acacia Pharma Group Plc
- GlaxoSmithKline PLC
- Helsinn Healthcare SA.
- Heron Therapeutics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe In Vitro Toxicity Testing Market, by Type
1.4.2 Europe In Vitro Toxicity Testing Market, by Technology
1.4.3 Europe In Vitro Toxicity Testing Market, by End User
1.4.4 Europe In Vitro Toxicity Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe In Vitro Toxicity Testing Market by Type
3.1 Europe Absorption Market by Country
3.2 Europe Toxic Substances Market by Country
3.3 Europe Dose Market by Country
Chapter 4. Europe In Vitro Toxicity Testing Market by Technology
4.1 Europe Cell Culture Technologies Market by Country
4.2 Europe High Throughput Technologies Market by Country
4.3 Europe Toxicogenomics Market by Country
Chapter 5. Europe In Vitro Toxicity Testing Market by End User
5.1 Europe Cosmetics & Households Products Market by Country
5.2 Europe Pharmaceuticals Industry Market by Country
5.3 Europe Food Industry Market by Country
5.4 Europe Chemicals Industry Market by Country
Chapter 6. Europe In Vitro Toxicity Testing Market by Country
6.1 Germany In Vitro Toxicity Testing Market
6.1.1 Germany In Vitro Toxicity Testing Market by Type
6.1.2 Germany In Vitro Toxicity Testing Market by Technology
6.1.3 Germany In Vitro Toxicity Testing Market by End User
6.2 UK In Vitro Toxicity Testing Market
6.2.1 UK In Vitro Toxicity Testing Market by Type
6.2.2 UK In Vitro Toxicity Testing Market by Technology
6.2.3 UK In Vitro Toxicity Testing Market by End User
6.3 France In Vitro Toxicity Testing Market
6.3.1 France In Vitro Toxicity Testing Market by Type
6.3.2 France In Vitro Toxicity Testing Market by Technology
6.3.3 France In Vitro Toxicity Testing Market by End User
6.4 Russia In Vitro Toxicity Testing Market
6.4.1 Russia In Vitro Toxicity Testing Market by Type
6.4.2 Russia In Vitro Toxicity Testing Market by Technology
6.4.3 Russia In Vitro Toxicity Testing Market by End User
6.5 Spain In Vitro Toxicity Testing Market
6.5.1 Spain In Vitro Toxicity Testing Market by Type
6.5.2 Spain In Vitro Toxicity Testing Market by Technology
6.5.3 Spain In Vitro Toxicity Testing Market by End User
6.6 Italy In Vitro Toxicity Testing Market
6.6.1 Italy In Vitro Toxicity Testing Market by Type
6.6.2 Italy In Vitro Toxicity Testing Market by Technology
6.6.3 Italy In Vitro Toxicity Testing Market by End User
6.7 Rest of Europe In Vitro Toxicity Testing Market
6.7.1 Rest of Europe In Vitro Toxicity Testing Market by Type
6.7.2 Rest of Europe In Vitro Toxicity Testing Market by Technology
6.7.3 Rest of Europe In Vitro Toxicity Testing Market by End User
Chapter 7. Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 General Electric (GE) Co.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 AstraZeneca PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Catalent, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Laboratory Corporation of America Holdings (Covance, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Acquisition and Mergers:
7.6 Acacia Pharma Group Plc
7.6.1 Company Overview
7.7 GlaxoSmithKline PLC (TESARO, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Helsinn Healthcare SA.
7.8.1 Company Overview
7.9 Heron Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
TABLE 1 Europe In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 2 Europe In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 3 Europe In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 4 Europe In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 5 Europe Absorption Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Absorption Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Toxic Substances Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Toxic Substances Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Dose Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Dose Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 12 Europe In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 13 Europe Cell Culture Technologies Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Cell Culture Technologies Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe High Throughput Technologies Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe High Throughput Technologies Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Toxicogenomics Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Toxicogenomics Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 Europe In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 Europe Cosmetics & Households Products Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Cosmetics & Households Products Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Pharmaceuticals Industry Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Pharmaceuticals Industry Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Food Industry Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Food Industry Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Chemicals Industry Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Chemicals Industry Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe In Vitro Toxicity Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe In Vitro Toxicity Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 Germany In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 32 Germany In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 33 Germany In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 34 Germany In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 35 Germany In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 36 Germany In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 37 Germany In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 38 Germany In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 39 UK In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 40 UK In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 41 UK In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 42 UK In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 43 UK In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 44 UK In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 45 UK In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 46 UK In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 47 France In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 48 France In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 49 France In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 50 France In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 51 France In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 52 France In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 53 France In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 France In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 Russia In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 56 Russia In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 57 Russia In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 58 Russia In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 59 Russia In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 60 Russia In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 61 Russia In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 62 Russia In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 63 Spain In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 64 Spain In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 65 Spain In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 66 Spain In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 67 Spain In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 68 Spain In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 69 Spain In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 70 Spain In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 71 Italy In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 72 Italy In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 73 Italy In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 74 Italy In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 75 Italy In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 76 Italy In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 77 Italy In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 78 Italy In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 79 Rest of Europe In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 80 Rest of Europe In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 81 Rest of Europe In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 82 Rest of Europe In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 83 Rest of Europe In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 84 Rest of Europe In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 85 Rest of Europe In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 86 Rest of Europe In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 KEY INFORMATION – GENERAL ELECTRIC (GE) CO.
TABLE 89 KEY INFORMATION – ASTRAZENECA PLC
TABLE 90 Key information – CATALENT, INC.
TABLE 91 Key Information – Laboratory Corporation of America holdings
TABLE 92 Key Information – Acacia Pharma Group Plc
TABLE 93 Key Information – GlaxoSmithKline PLC
TABLE 94 Key Information – Helsinn Healthcare SA.
TABLE 95 Key Information – Heron Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: thermo fisher scientific, inc.
FIG 3 Swot analysis: General electric (GE) Co.